In Vivo Endochondral Bone Formation Using a Bone Morphogenetic Protein 2 Adenoviral Vector
- 1 September 1999
- journal article
- research article
- Published by Mary Ann Liebert Inc in Human Gene Therapy
- Vol. 10 (13), 2245-2253
- https://doi.org/10.1089/10430349950017220
Abstract
Bone morphogenetic proteins (BMPs) are polypeptides that induce ectopic bone formation in standard rat in vivo assay systems. Previous studies have demonstrated the clinical utility of these proteins in spinal fusion, fracture healing, and prosthetic joint stabilization. Gene therapy is also a theoretically attractive technique to express BMPs clinically, since long-term, regulatable gene expression and systemic delivery with tissue-specific expression may be possible in future. This study was performed to determine whether an adenoviral vector containing the BMP-2 gene can be used to express BMP-2 in vitro and promote endochondral bone formation in vivo. In vitro, U87 MG cells transduced per cell with 20 MOI of an adenoviral construct containing the BMP-2 gene under the control of the universal CMV promoter (Ad-BMP-2) showed positive antibody staining for the BMP-2 protein at posttransfection day 2. The synthesis and secretion of active BMP-2 into the conditioned medium of Ad-BMP-2-transduced 293 cells were confirmed by Western blot analysis and the induction of alkaline phosphatase activity in a W-20 stromal cell assay. In vivo, Sprague-Dawley rats and athymic nude rats were injected with Ad-BMP-2 in the thigh musculature and were sacrificed on day 3, 6, 9, 12, 16, 21, 60, and 110 for histological analysis. The Sprague-Dawley rats showed evidence of acute inflammation, without ectopic bone formation, at the injection sites. In the athymic nude rats, BMP-2 gene therapy induced mesenchymal stem cell chemotaxis and proliferation, with subsequent differentiation to chondrocytes. The chondrocytes secreted a cartilaginous matrix, which then mineralized and was replaced by mature bone. This study demonstrates that a BMP-2 adenoviral vector can be utilized to produce BMP-2 by striated muscle cells in athymic nude rats, leading to endochondral bone formation. However, in immunocompetent animals the endochondral response is attenuated, secondary to the massive immune response elicited by the first-generation adenoviral construct.Keywords
This publication has 51 references indexed in Scilit:
- Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodentsJournal of Orthopaedic Research, 1998
- Liver-Directed Gene Transfer in Non-Human PrimatesHuman Gene Therapy, 1997
- Overexpression of an Osteogenic Morphogen in Fibrodysplasia Ossificans ProgressivaNew England Journal of Medicine, 1996
- Repair of critical size rat calvarial defects using extracellular matrix protein gelsJournal of Neurosurgery, 1995
- Intermittent Cauda Equina Compression An Experimental Study of the Porcine Cauda Equina With Analyses of Nerve Impulse Conduction PropertiesSpine, 1995
- Growth factors and the regulation of bone remodeling.JCI Insight, 1988
- The Role of Bone Marrow in Bone Morphogenetic Protein-induced Repair of Femoral Massive Diaphyseal DefectsPublished by Wolters Kluwer Health ,1982
- The Nature of Bone Morphogenetic Protein (BMP) Fractions Derived from Bovine Bone Matrix GelatinPublished by Wolters Kluwer Health ,1982
- The Reaction of the Dura To Bone Morphogenetic Protein (BMP) in Repair of Skull DefectsAnnals of Surgery, 1982
- Characteristics of a Human Cell Line Transformed by DNA from Human Adenovirus Type 5Journal of General Virology, 1977